Free Trial

Sherwin-Williams (NYSE:SHW) Given New $380.00 Price Target at Loop Capital

Sherwin-Williams logo with Basic Materials background

Sherwin-Williams (NYSE:SHW - Get Free Report) had its price objective decreased by research analysts at Loop Capital from $395.00 to $380.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has a "buy" rating on the specialty chemicals company's stock. Loop Capital's target price indicates a potential upside of 12.04% from the company's current price.

Other research analysts also recently issued reports about the company. UBS Group boosted their target price on Sherwin-Williams from $398.00 to $410.00 and gave the stock a "buy" rating in a research note on Wednesday, July 9th. Bank of America boosted their price target on Sherwin-Williams from $289.00 to $296.00 and gave the stock an "underperform" rating in a research note on Monday, June 23rd. Citigroup dropped their target price on shares of Sherwin-Williams from $385.00 to $375.00 and set a "neutral" rating on the stock in a research report on Wednesday. Royal Bank Of Canada boosted their target price on shares of Sherwin-Williams from $410.00 to $420.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Finally, Barclays dropped their price objective on shares of Sherwin-Williams from $385.00 to $355.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 1st. One analyst has rated the stock with a sell rating, six have issued a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Sherwin-Williams presently has a consensus rating of "Moderate Buy" and a consensus price target of $383.33.

Read Our Latest Stock Analysis on SHW

Sherwin-Williams Stock Down 0.3%

SHW traded down $1.06 on Wednesday, hitting $339.15. The company had a trading volume of 477,609 shares, compared to its average volume of 1,750,565. The stock has a fifty day moving average price of $348.62 and a 200-day moving average price of $348.06. Sherwin-Williams has a 12-month low of $308.84 and a 12-month high of $400.42. The company has a debt-to-equity ratio of 1.78, a quick ratio of 0.45 and a current ratio of 0.78. The stock has a market capitalization of $84.99 billion, a price-to-earnings ratio of 33.65, a P/E/G ratio of 3.25 and a beta of 1.18.

Sherwin-Williams (NYSE:SHW - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The specialty chemicals company reported $3.38 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.76 by ($0.38). Sherwin-Williams had a return on equity of 66.91% and a net margin of 11.03%. The firm had revenue of $6.31 billion during the quarter, compared to analysts' expectations of $6.31 billion. During the same period in the previous year, the firm earned $3.70 EPS. The firm's quarterly revenue was up .6% on a year-over-year basis. Analysts predict that Sherwin-Williams will post 12 EPS for the current fiscal year.

Institutional Trading of Sherwin-Williams

Hedge funds have recently added to or reduced their stakes in the company. Coppell Advisory Solutions LLC lifted its position in shares of Sherwin-Williams by 2.7% during the 4th quarter. Coppell Advisory Solutions LLC now owns 1,146 shares of the specialty chemicals company's stock valued at $388,000 after buying an additional 30 shares in the last quarter. Opal Wealth Advisors LLC lifted its stake in Sherwin-Williams by 4.2% in the 1st quarter. Opal Wealth Advisors LLC now owns 791 shares of the specialty chemicals company's stock valued at $276,000 after buying an additional 32 shares in the last quarter. Nicolet Advisory Services LLC lifted its stake in Sherwin-Williams by 3.1% in the 1st quarter. Nicolet Advisory Services LLC now owns 1,096 shares of the specialty chemicals company's stock valued at $362,000 after buying an additional 33 shares in the last quarter. CBIZ Investment Advisory Services LLC lifted its stake in Sherwin-Williams by 41.8% in the 1st quarter. CBIZ Investment Advisory Services LLC now owns 112 shares of the specialty chemicals company's stock valued at $39,000 after buying an additional 33 shares in the last quarter. Finally, Integrated Wealth Concepts LLC lifted its position in shares of Sherwin-Williams by 1.3% in the first quarter. Integrated Wealth Concepts LLC now owns 2,655 shares of the specialty chemicals company's stock valued at $927,000 after acquiring an additional 33 shares in the last quarter. 77.67% of the stock is owned by hedge funds and other institutional investors.

About Sherwin-Williams

(Get Free Report)

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.

Read More

Analyst Recommendations for Sherwin-Williams (NYSE:SHW)

Should You Invest $1,000 in Sherwin-Williams Right Now?

Before you consider Sherwin-Williams, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.

While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines